Volume 37 Issue 5
Sep.  2021
Turn off MathJax
Article Contents
CHEN Hai-xiong, LI Min-yan, DU Yong-xing, LIN Qiu-hong, HU Qiu-gen, YANG Shao-min. Exploring the Correlation between Syndrome Differentiation of Traditional Chinese Medicine of Non-Ischemic Cardiomyopathy and Myocardial Fibrosis Based on Cardiac MRI[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(5): 678-681. doi: 10.14148/j.issn.1672-0482.2021.0678
Citation: CHEN Hai-xiong, LI Min-yan, DU Yong-xing, LIN Qiu-hong, HU Qiu-gen, YANG Shao-min. Exploring the Correlation between Syndrome Differentiation of Traditional Chinese Medicine of Non-Ischemic Cardiomyopathy and Myocardial Fibrosis Based on Cardiac MRI[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(5): 678-681. doi: 10.14148/j.issn.1672-0482.2021.0678

Exploring the Correlation between Syndrome Differentiation of Traditional Chinese Medicine of Non-Ischemic Cardiomyopathy and Myocardial Fibrosis Based on Cardiac MRI

doi: 10.14148/j.issn.1672-0482.2021.0678
  • Received Date: 2021-05-25
    Available Online: 2021-12-21
  • Publish Date: 2021-09-10
  • OBJECTIVE  To investigate the correlation between syndrome differentiation of traditional Chinese medicine (TCM) of non-ischemic cardiomyopathy (NICM) and parameters of the cardiac volume and function, along with myocardial fibrosis.METHODS  We selected 64 patients clinically diagnosed with NICM from September 2019 to October 2020 at Shunde Hospital of Southern Medical University. The patients were divided into three groups according to TCM syndrome differentiation, including the syndrome of stasis obstructing the heat blood, syndrome of turbid phlegm obstruction, as well as the syndrome of neither stasis obstructing the heat blood nor turbid phlegm obstruction (heart yang insufficiency, heart-kidney yin deficiency, deficiency of both qi and yin, and cold congealing heart vessel). All patients underwent cardiac magnetic resonance (CMR), which includes black-blood sequence, bright-blood sequence, and late gadolinium enhancement (LGE). The CMR bright-blood sequence images were post-processed to obtain parameters of cardiac volume and function, including left ventricular ejection fraction (LVEF), left ventricular end-diastolic volume index (LVEDVI), left ventricular end-systolic volume index (LVESVI), left ventricular stroke volume index (LVSVI), left ventricular cardiac output index (LVCOI), and left ventricular mass index (LVMI). The LGE left ventricular images were divided into 17 segments according to the American Heart Association (AHA) recommendations and were classified into grades one to three according to the segmental distribution of abnormal ventricular wall enhancement. In addition, statistical analysis was performed on the above data.RESULTS  The differences were statistically significant (P < 0.05) when comparing the LVEF in the turbid phlegm obstruction group and neither stasis obstructing the heat blood nor turbid phlegm obstruction groups. The differences were statistically significant (P < 0.05, P < 0.01) when comparing the LVEDVI in the turbid phlegm obstruction group, the stasis obstructing the heat blood group, as well as neither stasis obstructing the heat blood nor turbid phlegm obstruction groups. The differences were statistically significant (P < 0.01) when comparing the LVESVI in the turbid phlegm obstruction group and neither stasis obstructing the heat blood nor turbid phlegm obstruction groups. The difference was statistically significant (P < 0.05) when comparing myocardial fibrosis degree in the stasis obstructing the heat blood group with the turbid phlegm obstruction group.CONCLUSION  The TCM syndrome differentiation of NICM has some correlation with parameters of the cardiac volume and function as well as myocardial fibrosis degree. Thus, this study provides new ideas for objective research and new methods for revealing the essence of Chinese medicine through the semi-quantitative and quantitative study of TCM syndrome differentiation combined with modern magnetic resonance technology.

     

  • loading
  • [1]
    MAURICIO P, EDUARDO RL, ANDRE Z, et al. Sudden cardiac death markers in non-ischemic cardiomyopathy[J]. J Electrocardiol, 2016, 49(3): 446-451. doi: 10.1016/j.jelectrocard.2016.03.012
    [2]
    国家技术监督局. 中医临床诊疗术语(疾病部分): GB/T 16751.1-1997[S/OL]. [2021-08-29]. https://max.book118.com/html/2019/0418/8025106105002017.shtm.
    [3]
    罗文杰, 吴焕林, 王侠, 等. 冠心病证候诊断方法及分型文献研究[J]. 中国中西医结合杂志, 2012, 32(6): 843-845. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201206041.htm
    [4]
    于海峰. 从心痹辨治扩张型心肌病的体会[J]. 上海中医药杂志, 2014, 48(1): 61-62. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ201401029.htm
    [5]
    SEGURA AM, FRAZIER OH, BUJA LM. Fibrosis and heart failure[J]. Heart Fail Rev, 2014, 19(2): 173-185. doi: 10.1007/s10741-012-9365-4
    [6]
    中华医学会心血管病学分会, 中华心血管病杂志编辑委员会, 中国心肌病诊断与治疗建议工作组. 心肌病诊断与治疗建议[J]. 中华心血管病杂志, 2007, 35(1): 5-16. doi: 10.3760/j:issn:0253-3758.2007.01.003
    [7]
    周仲瑛. 中医内科学[M]. 北京: 中国中医药出版社, 2012: 407-409.
    [8]
    胸痹心痛的诊断依据、证候分类、疗效评定: 中华人民共和国中医药行业标准《中医内科病证诊断疗效标准》(ZY/T001.1-94)[J]. 辽宁中医药大学学报, 2016, 18(7): 32. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201607011.htm
    [9]
    ELOISA A, NAVNEET N, WILLIAM DG, et al. The MOGE(S)classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation[J]. J Am Coll Cardiol, 2013, 62(22): 2046-2072. doi: 10.1016/j.jacc.2013.08.1644
    [10]
    刘文华, 唐少华, 许静芳, 等. 经典理论指导辨证治疗胸痹的临床体会[J]. 辽宁中医杂志, 2011, 38(2): 264-266. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201102030.htm
    [11]
    ILES L, PFLUGER H, LEFKOVITS L, et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death[J]. J Am Coll Cardiol, 2011, 57(7): 821-828. doi: 10.1016/j.jacc.2010.06.062
    [12]
    丁然, 陆小左. 基于有无痛胸分型的胸痹脉象中医客观化研究[J]. 中医药信息, 2018, 35(2): 66-69. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXN201802017.htm
    [13]
    唐宗海. 血证论[M]. 天津: 天津科学技术出版社, 2003: 85.
    [14]
    韦红, 阎国良, 李越华. 从痰瘀论治心肌纤维化的机理初探[J]. 陕西中医药大学学报, 2019, 42(1): 38-39, 46. https://www.cnki.com.cn/Article/CJFDTOTAL-SXXY201901014.htm
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Article Metrics

    Article views (192) PDF downloads(97) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return